Pulse Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 401K | 264K | 86K | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 370K | 519K | 279K | 267K | 0 | 0 | 0 | 0 |
| Gross Profit | 31K | -255K | -193K | -267K | 0 | 0 | 0 | 0 |
| R&D Expenses | 12.6M | 10.9M | 11.4M | 12.1M | 10.3M | 10.7M | 7.7M | 7.2M |
| Operating Expenses | 19.2M | 18.0M | 20.2M | 20.0M | 18.0M | 20.3M | 13.7M | 11.7M |
| Operating Income | -19.1M | -18.3M | -20.4M | -20.3M | -18.0M | -20.3M | -13.7M | -11.7M |
| Other Income / Gains | 569K | 820K | 982K | 1.1M | 1.2M | 876K | 975K | 343K |
| Net Income | -18.6M | -17.4M | -19.4M | -19.2M | -16.8M | -19.4M | -12.7M | -11.4M |
| EPS (Diluted) | -0.26 | -0.26 | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 | -0.20 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.077 | -0.966 | -2.244 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.6M | 0 | 0 | 8.2M | 7.7M | 9.6M | 6.0M | 4.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.6M | 7.1M | 8.8M | 8.2M | 7.7M | 9.6M | 6.0M | 4.5M |
| Other Expenses | 0 | 0 | 0 | -267K | 0 | 0 | 0 | 0 |
| Cost And Expenses | 19.6M | 18.5M | 20.5M | 20.3M | 18.0M | 20.3M | 13.7M | 11.7M |
| Interest Income | 593K | 853K | 1.0M | 1.1M | 1.2M | 876K | 975K | 343K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 255K | 259K | 256K | 267K | 283K | 287K | 294K | 298K |
| Ebitda | -18.9M | -17.2M | -19.1M | -18.9M | -16.5M | -19.1M | -12.4M | -11.1M |
| Ebitdaratio | -47.12 | -65.053 | -222.43 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -47.756 | -69.14 | -236.826 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -18.6M | -17.4M | -19.4M | -19.2M | -16.8M | -19.4M | -12.7M | -11.4M |
| Income Before Tax Ratio | -46.337 | -66.034 | -225.407 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -46.337 | -66.034 | -225.407 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.26 | -0.26 | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 | -0.20 |
| Weighted Average Shs Out | 67.8M | 67.4M | 67.4M | 67.3M | 67.1M | 58.4M | 61.1M | 57.2M |
| Weighted Average Shs Out Dil | 67.8M | 67.4M | 67.4M | 67.3M | 67.1M | 58.4M | 61.1M | 57.2M |